Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Riluzole for severe traumatic brain injury
IRCT20191104045328N6Phase 3Completed
- Sponsor
- Arak University of Medical Sciences
- Start
- May 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of riluzole in traumatic brain injury (TBI), sponsored by Arak University of Medical Sciences. Started May 2021; status: completed.
02
Drugs
riluzole
03
Conditions
traumatic brain injury (TBI)
Beyond the preview
Go deeper on IRCT20191104045328N6.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20191104045328N6.